Healthcare provider profile · identity verified

Jacqueline M Devaney, FNP

Nurse Practitioner · HILLSBORO, OR · NPI 1790370096

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Memantine Hcl	Memantine Hcl	533	59
Donepezil Hcl	Donepezil Hcl	358	43
Atorvastatin Calcium	Atorvastatin Calcium	236	32
Gabapentin	Gabapentin	235	35
Levothyroxine Sodium	Levothyroxine Sodium	226	23
Amlodipine Besylate	Amlodipine Besylate	219	24
Omeprazole	Omeprazole	202	30
Metoprolol Succinate	Metoprolol Succinate	188	26
Quetiapine Fumarate	Quetiapine Fumarate	173	22
Eliquis	Apixaban	168	24
Furosemide	Furosemide	151	28
Oxycodone Hcl	Oxycodone Hcl	147	43
Lisinopril	Lisinopril	146	19
Tamsulosin Hcl	Tamsulosin Hcl	145	18
Trazodone Hcl	Trazodone Hcl	143	20
Risperidone	Risperidone	126	16
Losartan Potassium	Losartan Potassium	122	19
Metformin Hcl	Metformin Hcl	111	14
Rivastigmine	Rivastigmine	109	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	16
Mirtazapine	Mirtazapine	103	16
Famotidine	Famotidine	100	16
Diclofenac Sodium	Diclofenac Sodium	87	28
Metformin Hcl Er	Metformin Hcl	83	11
Carvedilol	Carvedilol	82	11
Torsemide	Torsemide	82	11
Duloxetine Hcl	Duloxetine Hcl	76	suppressed
Morphine Sulfate	Morphine Sulfate	73	32
Metoprolol Tartrate	Metoprolol Tartrate	69	11
Spironolactone	Spironolactone	69	suppressed
Tramadol Hcl	Tramadol Hcl	68	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	68	12
Divalproex Sodium	Divalproex Sodium	66	suppressed
Baclofen	Baclofen	65	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	64	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	64	suppressed
Ondansetron Odt	Ondansetron	64	48
Allopurinol	Allopurinol	61	suppressed
Myrbetriq	Mirabegron	61	suppressed
Cephalexin	Cephalexin	60	46
Spiriva Respimat	Tiotropium Bromide	59	11
Nortriptyline Hcl	Nortriptyline Hcl	58	suppressed
Clopidogrel	Clopidogrel Bisulfate	55	suppressed
Buspirone Hcl	Buspirone Hcl	54	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	11
Pantoprazole Sodium	Pantoprazole Sodium	52	12
Albuterol Sulfate Hfa	Albuterol Sulfate	51	19
Amiodarone Hcl	Amiodarone Hcl	50	suppressed
Atropine Sulfate	Atropine Sulfate	50	31
Rosuvastatin Calcium	Rosuvastatin Calcium	50	suppressed
Potassium Chloride	Potassium Chloride	49	suppressed
Sertraline Hcl	Sertraline Hcl	49	suppressed
Risperidone Odt	Risperidone	48	suppressed
Haloperidol Lactate	Haloperidol Lactate	47	28
Finasteride	Finasteride	45	suppressed
Lorazepam	Lorazepam	45	12
Clozapine	Clozapine	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	19
Latanoprost	Latanoprost	42	suppressed
Olanzapine	Olanzapine	42	suppressed
Oxycontin	Oxycodone Hcl	42	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Levetiracetam	Levetiracetam	41	suppressed
Olanzapine Odt	Olanzapine	40	suppressed
Bupropion Xl	Bupropion Hcl	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Clonazepam	Clonazepam	38	suppressed
Lactulose	Lactulose	38	15
Prednisone	Prednisone	38	suppressed
Aripiprazole	Aripiprazole	35	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Bumetanide	Bumetanide	33	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Nyamyc	Nystatin	31	18
Lidocaine	Lidocaine	30	11
Klor-Con 10	Potassium Chloride	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	17
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Lorazepam Intensol	Lorazepam	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Mirabegron Er	Mirabegron	26	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Prazosin Hcl	Prazosin Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	17
Entresto	Sacubitril/Valsartan	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Atenolol	Atenolol	20	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Nystatin	Nystatin	19	11
Pregabalin	Pregabalin	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Naltrexone Hcl	Naltrexone Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	16	suppressed
Simvastatin	Simvastatin	16	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Entacapone	Entacapone	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Donepezil Hcl Odt	Donepezil Hcl	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lithium Carbonate Er	Lithium Carbonate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Methimazole	Methimazole	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Valsartan	Valsartan	12	suppressed
Acetic Acid	Acetic Acid	11	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Leflunomide	Leflunomide	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error